Indications and uses
HELPS PREVENT SUNBURN HIGHER SPF GIVES MORE SUNBURN PROTECTION
HELPS PREVENT SUNBURN HIGHER SPF GIVES MORE SUNBURN PROTECTION
APPLY LIBERALLY 20 MINUTES BEFORE SUN EXPOSURE AND AS NEEDED FOR CHILDREN UNDER 6 MONTHS OF AGE, ASK A DOCTOR
AVOBENZONE 3.00%, HOMOSALATE 7.5%, OCTISALATE 5.00%, OCTOCRYLENE 2.75%, OXYBENZONE 4.00%
SUNSCREEN
FOR EXTERNAL USE ONLY
WHEN USING THIS PRODUCT:
STOP USE AND ASK A DOCTOR IF RASH OR IRRITATION DEVELOPS OR LASTS
LIMITING SUN EXPOSURE, WEARING PROTECTIVE CLOTHING AND USING SUNSCREEN REDUCES THE RISK OF AGING, SKIN CANCER AND OTHER HARMFUL EFFECTS OF THE SUN.
WATER, ADIPIC ACID/ DIETHYLENE DIGLYCOL GLYCERIN CROSSPOLYMER, C 12-15 ALKYL BENZOATE, ALOE BARBADENSIS LEAF EXTRACT, RETINYL PALMITATE, TOCOPHERYL ACETATE SODIUM ASCORBYL PHOSPHATE, STEARETH-21, TRIETHANOLAMINE, PROPYLENE GLYCOL, DECYL GLUCOSIDE, SORBITAN STEARATE, STEARETH-2, ACRYLATES/ C 10-30 ALKYL ACETATE CROSSPOLYMER, DIAZOLIDINYL UREA, METHYLPARABEN, CARBOMER, HYDROXYPROPYL, METHYLCELLULOSE, DISODIUM EDTA, PROPYLPARABEN
SPF30LotionLabel.jpg
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51401-030-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-67b4-f424-e053-dadaa90a57ce | SKIN STRONG SKIN EQUIPMENT - SPF 30 SUNSCREEN LOTION - DRUG FACTS LABEL |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51401-030-01 | SKIN STRONG - SKIN EQUIPMENTSPF 30 SUNSCREEN | 118 mL in 1 BOTTLE, PUMP | LOTION | 118 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51401-030 | SKIN STRONG - SKIN EQUIPMENT SPF 30 SUNSCREEN (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE) LOTION [TRUE BALANCE ATHLETICS LLC ] | 2 | Legacy NDC, 1 package rows | 20121222_683d6fd0-ea36-4fdf-932c-8c44bf80ab2d.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 2 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 2 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 2 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 2 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 2 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 2 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 2 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 2 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 2 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 2 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 2 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 2 | |
| SODIUM ASCORBYL PHOSPHATE | INACTIVE INGREDIENT | 836SJG51DR | 2 | |
| STEARETH-21 | INACTIVE INGREDIENT | 53J3F32P58 | 2 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51401-030 | 51401-030-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AVOBENZONE | G63QQF2NOX | ACTIB |
| HOMOSALATE | V06SV4M95S | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
| OCTOCRYLENE | 5A68WGF6WM | ACTIB |
| OXYBENZONE | 95OOS7VE0Y | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALKYL (C12-15) BENZOATE | A9EJ3J61HQ | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| VITAMIN A PALMITATE | 1D1K0N0VVC | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| SODIUM ASCORBYL PHOSPHATE | 836SJG51DR | IACT |
| STEARETH-21 | 53J3F32P58 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | CREAM / TOPICAL | 3 %w/w | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e3470bcf-caa8-443f-91d5-329acba12c76 | 683d6fd0-ea36-4fdf-932c-8c44bf80ab2d | 2012-12-19 | Warnings | e3470bcf-caa8-443f-91d5-329acba12c76 683d6fd0-ea36-4fdf-932c-8c44bf80ab2d |
Adverse event summaries are temporarily unavailable. Other product information remains available.